Tags » Business 2

Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers by ANDREW POLLACK and SABRINA TAVERNISE


A pharmaceutical company buys old drugs and increases the price multifold, a profitable business model that is drawing anger and making the traditional drug industry nervous. 12 more words

Hadi Aboukhater

An Event At The Graduate Center

krugman.blogs.nytimes.com – Janet Gornick, Branko Milanovic, and yours truly will be talking about LIS and what it does Tuesday, October 6th, 2015, 11:30 a.m. to 12:30 p.m. 22 more words


Puzzled By Peter Gourevitch

krugman.blogs.nytimes.com – Peter Gourevitch has a followup on politics and economics that leaves me, if anything, more puzzled about what’s going on.

He notes that… 109 more words


The Blanchard Touch

krugman.blogs.nytimes.com – Steven Pearlstein has a very nice profile of Olivier Blanchard, a world-class macroeconomist who went on to become an even more towering figure as chief economist at the IMF. 89 more words


USA TODAY: "Turntable Health is no ordinary primary care clinic. The idea stemmed from a conversation between Tony Hsieh, CEO of the online shoes and clothing emporium Zappos.com"

Christina Farr, Special for USA TODAY

LAS VEGAS | AUGUST 26, 2015 — Walk into Turntable Health in downtown Las Vegas and you’d be forgiven for thinking you had stepped into a trendy technology start-up rather than a doctor’s office. 271 more words


Trade Negotiations Stall Over Drugs and Dairy, Extending Talks Another Day by JACKIE CALMES


Negotiators failed to reach an agreement over commercial protections for drug companies, leaving trade ministers to settle for a final round of talks on Sunday. 13 more words

Hadi Aboukhater